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INTRODUCTION 
The Purpose of this study was to perform excretion 
study of Tamoxifen and to Detect its main active 
metabolite 3-hydroxy-4-methoxy by GC-MS. 
Tamoxifen (C26H29NO with mol mass-371.515,fig-1) 
works against the effect of estrogen on  cell(an “anti-
estrogen)slows the growth of cancer cell and prevent 
original breast cancer from returning. It also has 
beneficial effect of menopausal estrogen replacement 
therapy such as lowering of blood cholesterol and 
slowing of osteoporosis
1
. 
In recent year, athletic competition has intensified to the 
point that increasing number of athletes are striving to 
upgrade their performance with the desire to be 
recognized as the best. Hence a sports person needs to 
keep himself vigorous, energetic, full of vitality and 
endurance. To achieve all this, some sports persons 
resort to pills and injections as shortcuts to success, as 
they don’t understand that good genes, scientific 
coaching, proper nutrition and dedication to the task are 
what ultimately bring them success
1-2
. The use of 
performance enhancing drugs is banned in sports
2-5
. 
 
Figure 1: Tamoxifen Chemical structure
10
. 
ABSTRACT  
Background; Tamoxifen, is a first-generation selective estrogen receptor modulator which is widely used for adjuvant breast 
cancer therapy. Tamoxifen metabolites completely bind to estrogen receptor on tumors as well as other tissues and target a 
nuclear complex that decreases DNA synthesis and inhibits estrogen effects. But these Selective Estrogen Receptor Modulators 
(SERMs) are classified as Prohibited substances according to the list of forbidden substances in sports by the World Anti-
Doping Agency (WADA) In sports male athletes use tamoxifen in fighting against increase of estrogen level in the body, breast 
swelling, gynecomastia and fat forming a pear-silhouette very successfully. Aim; In the present study Tamoxifen was 
investigated carefully by administering to a Healthy volunteer. Material and Method; Urine samples are collected at different 
hours from 1st day to 5th day and analyzed by GC-MS. Result; It was found that Tamoxifen is rapidly metabolized in to their 
metabolite 3-hydrohy-4-methoxy Tamoxifen. Urinary extracts were analyzed by Gas Chromatography-Mass spectrometric 
Detector by using Selective ion modulator (SIM) and targeted GC-MS techniques with accurate mass. By the GC-MS study it is 
observed that 3-hydroxy-4-methoxy Tamoxifen metabolite gives two neutral loss m/z value at 58 & 72,  but m/z value 58 
shows more abundance than 72m/z value, hence it was selected as the marker m/z  value to check the presence of metabolite in 
urine. Conclusion; After oral administration, Tamoxifen metabolite can be detected in to their maximum period up to 5 days. 
Key word: Doping, World Anti Doping Agency, Tamoxifen , GC-MSD, Human Urine , Solid phase Extraction 
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Doping is the administration of or use by a competing 
athlete of any substance foreign to the body of any 
physiological substance in abnormal quantities or taken 
by an abnormal route of entry into the body with the sole 
purpose of increasing in an artificial and unfair manner 
his/her performance in competition. To check such 
practice, The international Olympic committee 
(IOC)/WADA has devised a list of substance banned for 
use by sports persons. Tamoxifen recently included anti-
estrogenic substance in the WADA list of prohibited 
substance. This Drug is working as a selective Estrogen 
Receptor Modulator that activate/block the estrogen 
receptor by occupying the estrogen receptor site
6-8
. Use 
of Tamoxifen is prohibited in males because in male the 
anti-estrogen substance may cause an increase in the 
endogenous production of androgen and fights against 
increase in estrogen level in the body, breast swellings, 
gynecomastia. The objective of this study is to identify 
the activity of metabolite 3-hydroxy-4-methoxy 
Tamoxifen which is secondary metabolite from the 
primary major metabolites. After administration of 
single dose tamoxifen (20mg), the urine samples were 
collected at different hrs from the 1
st 
-5
th 
day. Tamoxifen 
is rapidly absorbed and attains steady-state serum level 
within 5 days. The Drug is extensively metabolized to 
N-demethyl-4-hydroxytamoxifen (major metabolite) and 
4-hydroxytamoxyfen (minor metabolite)primary 
metabolite. This primary metabolite further hydrolyzed 
in the form of secondary metabolites. Only the main 
major secondary metabolite 3-hydroxy-4-
methoxytamoxifen (C3H8N) gives two different neutral 
loss m/z value at 58 & 72. 58 m/z value selected for the 
presence of metabolite in urine because it shows more 
abundance than 72m/z value
 8-10
. The analytical method 
for analysis of the drug metabolism is Gas 
Chromatography Mass spectrometry (GCMS), because it 
is increasingly employed in the metabolic study of the 
drug with accurate mass measurement in order to predict 
unknown metabolites of Drug
8-10
. 
MATERIAL AND METHOD 
Methanol (HPLC grade), potassium carbonate & 
Anhydrous Sodium Sulphate were procured from Merck. 
Derivatising agents Tertiary butyl methyl ether (TBME) 
and N-Methyl-N-(trimethylsilyl) trifluoroacetamide 
[MSTFA] were procured from Across Organics and 
Sigma Aldrich. Β-glucuronidase was procured from 
Roche diagnostics. 17α- methyl testosterone & 
chlorotestosterone (clostebol) acetate & deuterated 
testosterone & Epitestosterone were procured from 
Sigma Aldrich. 
Preparation of Reagents 
1. Amberlite XAD2 
Mix 500g of XAD-2 in 500-600ml of acetone 
vigorously. Allow the mixture to stand for 10-15 min., 
aspirate the acetone & floating XAD-2 resin. Repeat this 
process two times. Place 500g of XAD-2 in a 1000ml 
glass bottle. Add 500-600ml of distilled water & mix 
vigorously. Allow the mixture to stand for 10-15min. 
Discard water layer and floating particles. .Repeat this 
process five times with methanol. Keep at ambient 
temperature.   
2. Amberlite XAD2 columns 
Take clean Pasteur pipette. Put one glass bead. To pack 
the column, pour XAD-2 slurry slowly with the help of 
another Pasteur pipette carefully up to the height of 
approximately 3 inch & there should not be any air 
bubble inside. Wash the column with distilled water. 
Similarly prepare requisite number of XAD-2 column 
prior to analysis. 
3. MSTFA/Iode-TMS/DTE (1000/2/2) 
Place 5ml of MSTFA in an amber colour glass bottle 
using a 5ml micropipette, add 10mg of dithioerythritol & 
mix well. Add 10ul of iodo –TMS using a micropipette. 
Keep at room temperature. 
 Preparation of internal standard:-  
Solution 1:- Weigh 1.0mg of 17α-methyl testosterone on 
the electronic balance; add 1.0ml ethanol to make 
1mg/ml as stock solution. 
Solution 2:- Weigh 1.3mg of chlorotestosterone acetate 
on the electronic balance, add 1.0ml ethanol to make 
1mg/ml as stock solution of chlorotestosterone 
(clostebol) . Take 100µl of solution 2 & add 900µl of 
ethanol to make 0.1mg/ml solution. 
Solution 3:- Prepare 1mg/ml solution of d3- testosterone 
& d3- epitestosterone separately in ethanol. 
Take 200µl stock solution1 in clean dry glass test tube & 
add 10µl of working solution -2 (0.1mg/ml solution), 
add 16 & 4µl from solution 3 respectively [d3-
testosterone ; d3-epitestosterone(4:1)] evaporate the 
ethanol. Reconstitute the dry residue with 10ml ethanol 
to make working Internal STD & keep in the refrigerator 
below 0ºC 
Sample collection Protocol 
After oral administration of tamoxifen (20mg), urine 
sample were collected at different interval for 5 days. A 
pinch of sodium azide was added in urine sample 
container as a preservative. The entire sample stored at 
20ᵒC after measuring pH and gravity. 
Sample Extraction 
1. Applied into XAD-2 column 
The sample extraction procedure for given drug involves 
solid phase extraction. 2-4 ml of urine sample based on 
specific gravity was taken & 50µl of internal standard 
was added in XAD-2 column. XAD-2 column was first 
washed with distilled water & then it was eluted 5 times 
with 0.5ml methanol each. Squeeze the XAD-2 column 
properly to remove remaining methanol in the screw test 
tube. The hydrolysis process was carried out at 60ºC for 
1 hour. The solution was cooled to room temp. & the pH 
was adjusted to 9-10 adding 250µl of K2CO3.The 
mixture was extracted with 5ml of tertiary- butyl methyl 
ether; after horizontal shaking for 10 min & 
centrifugation (5 min, 3000rpm), the organic layer was 
separated by adding 1gm Na2SO4.The separated organic 
layer was taken in derivatizing tube which was dried up 
under N2 evaporator at 60ºC. 
2. Derivatization 
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The sample was derivatized by adding 50µl 
MSTFA/iodo TMS/dithiocrythritol (1000/2/2). 
Derivatization was carried out at 60◦C for 30 minutes. 
Derivatizing tube was then transferred into 200µl 
conical glass vial & then 2µl was injected into GCMS. 
3. Instrumentation 
The analyses were performed in a Hewlett Packard GC–
MSD system. The GC was carried out using a ultra-1 
dimethylpolymer polysiloxane fused silica capillary 
column from Agilent Technologies (ultra1, 17-m × 0.22-
mm id, 0.11-μm), operated in SIM and scan modes. Two 
micro liters was injected into the GC–MSD in the split 
mode (1:11).The GC–MSD parameters included a 
column flow of 0.2mL/min of Helium. The injector 
temperature was 280ºC in the split mode. The oven 
temperature was programmed from 180°C,1 min hold to 
229°C at a rate of 3°C/min and then from 229°C to 
300°C  at rate of 40°C/min. The final Run time was 23.1 
min. It was operated in the SIM mode using a post run 
macro for anabolic steroids including ions m/ z 58, 72, 
and 489 at the retention time of Tamoxifen metabolite of 
tamoxifen. (Figure 4). 
RESULT AND DISSCUSION 
RESULTS 
After oral administration  of single dose (20mg) 
tamoxifen to a healthy volunteer, urine samples were 
collected and studied by the GC-MS .The mass spectrum 
of tamoxifen in product ion sim mode was studied 
carefully ,which was chemically characterized and 
observed that Tamoxifen firstly gives seven major 
metabolite(fig-2), these metabolite further hydrolyzed in 
to the secondary metabolite in urine. In the resulted 
secondary metabolite it seems that the only 3-hydroxy-4-
methoxy tamoxifen (Secondary metabolite) shows the 
main activity than other metabolite. A metabolite was 
obtained by the accurate extraction of the m/z 390.2060 
(Fig.3). On the basis of accurate mass results, M6 had 
additional two oxygen atoms and a reduced carbon atom 
than unchanged tamoxifen, which showed the existence 
of two hydroxyl groups. Product ion at m/z 58.0655 
(C3H7N, masscalc = 58.0651) in targeted MS/MS 
experiment indicated the presence of N-desmethylated 
side chain. 
 
 
Figure 2: The chemical structures of tamoxifen and its new metabolites in human urine
2
. 
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Figure 3:  Proposed mass spectrometry fragmentation pathway of α,3,-hydroxy-4- methoxy-tamoxifen2. 
 
By the GC-MS Chromatography study it observed 
that only 58 m/z value shows more abundance than 
72 m/z value in the Chromatogram, Therefore 58 m/z  
value selected as a marker m/z value to check the 
presence of tamoxifen metabolite in the urine 
sample(Fig-4b,4c).All urine samples collected at the 
different time intervals were examined by GC-MSD . 
A blank was also injected in GC-MS (Fig-4a) to 
observe the chromatogram and mass spectrum. It 
was observed that excretion of 3-hydroxy-4-methoxy 
tamoxifen which is a metabolite of tamoxifen started 
appearing in urine from the 1 hr. The highest peak 
concentration of this metabolite was observed at 8.5 
hrs after the administration of tamoxifen. No further 
excretion of metabolite was found after 75 hrs in 
urine as demonstrated with decrease in abundance 
from 8.5 hours as shown in figure no. 5 and Table 
no. 1 
 
Table 1: Abundance of m/z 58 of 3-Hydroxy-4-
Methoxy Tamoxifen Metabolite at Different hours: 
S.No. Hours pH Abundance of Tamoxifen 
Metabolite 
1 1hr 5.5 7,000 
2 2hr 6.0 3,000 
3 4hr 5.5 18,000 
4 6hr 6.0 35,000 
5 8.5hr 6.5 90,000 
6 11hr 6.5 55,000 
7 13.5hr 7.5 65,000 
8 19hr 6.5 45,000 
9 30hr 5.5 35,000 
10 51hr 6.0 20,000 
11 65hr 6.0 24,000 
12 75hr 6.0 3,000 
 
GC-MS Chromatograms showing Abundance of m/z 58 of 3-Hydroxy-4-Methoxy Tamoxifen. 
 
Figure 4a: The extraction ion chromatogram  and mass spectrum of  blank in targeted GCMS SIM mode . 
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Figure 4b: The extraction ion chromatogram and mass spectrum of 3-hydroxyl-4- methoxy tamoxifen  at 1hr in targeted 
GCMS SIM mode . 
 
Figure 4c: The extraction ion chromatogram and mass spectrum of 3-hydroxyl-4- methoxy tamoxifen  at 8.5hr in 
targeted GCMS SIM mode . 
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Figure 5: Abundance of Tamoxifen metabolites at 
different hours. 
DISSCUSION 
In sports athletes may be encouraged to treat the adverse 
effect of extensive abuse of anabolic androgenic steroid 
(suppuration of androgen and gynecomastia)by using 
anti-estrogen drug .Tamoxifen is prohibited in males 
because in male the anti-estrogen substance may cause 
and increase the endogenous production of androgen. 
Although Tamoxifen is beneficial in Breast Cancer 
therapy, it is a banned categorize drug in sports  by the 
World Anti Doping Agency due to their adverse effect. 
Tamoxifen is rapidly hydrolyzed in to their metabolite, 
after oral administration and these metabolites can be 
detected by the urinary excretion study up to 5 days.  
CONCLUSION 
Tamoxifen is an anti-estrogenic substance, which 
basically binds to estrogen receptor for blocking 
unwanted effect of estrogen
10
.These drugs are able to 
reduce gynecomastia and enhance testosterone 
production. Tamoxifen is quickly metabolized after oral 
administration into compound that binds to the estrogen 
receptor but do not activate it. Because of this 
competitive antagonism, tamoxifen act like a key broken 
off in the lock that prevents any other key(drug or 
metabolite) from being inserted, thereby preventing 
estrogen from binding to its receptor site. 
From the present study it is concluded that tamoxifen 
metabolite started excreting from 1
st
hr of oral 
administration and it remains in the body for a 
maximum period of 5 days which will help in its 
detection even after the administration of drug is 
stopped up to 5 days 
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